Work

Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.

Year: 2000

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: H C Pitot, R M Goldberg, J M Reid, J A Sloan, P A Skaff, C Erlichman, J Rubin, P A Burch, A A Adjei, S A Alberts, L J Schaaf, G Elfring, L L Miller

Institution: Mayo Clinic

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Center for Research Resources

Award: General Clinical Research Center

OpenAlex ID: W2125739525

FWCI: 1.203

Cites: 24

Cited by: 73

Related to: 10